Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Myelodysplastic Syndromes 2Lymphoma 2Leukemia, Myeloid, Acute 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, Non-Hodgkin 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Hematologic Neoplasms 1Anemia, Sickle Cell 1Anemia, Aplastic 1

Interventions

fludarabine 2Surveys and Questionnaires 2fludarabine phosphate 1Thiotepa 1Registries 1Range of Motion, Articular 1Protease Inhibitors 1Melphalan 1Interviews as Topic 1Erythrocyte Count 1Clofarabine 1Bone Marrow Transplantation 1Blood Transfusion 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Anemia, Sickle Cell × Bone Marrow Transplantation × Clear all
NCT07145411 2025-08-28

HOPE

Ossium Health, Inc.

Recruiting
10 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Aplastic, Anemia, Sickle Cell, Lymphoma, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡